Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Total Liabilities (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Total Liabilities for 2 consecutive years, with $36.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities fell 11.54% to $36.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $36.8 million, a 11.54% decrease, with the full-year FY2024 number at $36.4 million, changed N/A from a year prior.
  • Total Liabilities was $36.8 million for Q3 2025 at Pyxis Oncology, up from $35.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $41.6 million in Q3 2024 to a low of $32.8 million in Q1 2025.